RxDoctor Payments DataLook up a doctor →

Brad Klein, MD

Neurology · Abington, PANPI 1659572337

Payments from drug & device makers

$1,238,048in general payments, 2019–2025

Across 2,076 payments — averaging $596.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$717K
  • Lilly USA, LLC$160K
  • Lundbeck LLC$110K
  • Teva Pharmaceuticals USA, Inc.$84K
  • Amgen$51K
  • Eli Lilly$26K
  • plus $90K from 54 others
$4,200in research payments, 2019–2025

Across 1 payment — averaging $4200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$4K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)707$716,991
Lilly USA, LLC266$160,196
Lundbeck LLC177$109,571
Teva Pharmaceuticals USA, Inc.179$83,752
Amgen126$51,479
Eli Lilly39$26,235
Impel Pharmaceuticals Inc.62$20,895
Axsome Therapeutics, Inc.26$16,168
Biohaven Pharmaceuticals, Inc.30$13,596
Ipsen Biopharmaceuticals, Inc27$7,572
Promius Pharma LLC12$7,058
Scilex Pharmaceuticals Inc.24$5,946
Biohaven Pharmaceutical Holding Company Ltd.37$5,461
Pfizer64$3,111
Currax Pharmaceuticals LLC4$2,293
Biodelivery Sciences International, Inc.1$1,500
AstraZeneca(2 entities)38$973
Biogen8$533
Upsher-smith Laboratories LLC28$511
Argenx US, Inc.17$474
Zyla Life Sciences, Inc.1$350
Supernus Pharmaceuticals, Inc.44$341
Amneal Pharmaceuticals LLC19$336
UCB, Inc.16$304
Jazz Pharmaceuticals Inc.10$280
Novartis11$201
CSL Behring8$174
Johnson & Johnson(2 entities)6$121
MDD US Operations, LLC5$108
Sunovion Pharmaceuticals Inc.6$100
Genentech USA, Inc.4$94
Merz Pharmaceuticals, LLC5$94
Impel Pharmaceuticals LLC4$72
Tersera Therapeutics LLC4$71
Avion Pharmaceuticals4$68
Akcea Therapeutics, Inc.1$67
Almatica Pharma LLC3$65
Eisai Inc.3$64
Otsuka America Pharmaceutical, Inc.3$57
Grifols USA, LLC3$55
Assertio Therapeutics, Inc.3$54
EMD Serono, Inc.3$52
SK Life Science, Inc.3$48
Abbott2$40
Adamas Pharmaceuticals, Inc.2$38
Bausch Health US, LLC2$37
Boston Scientific2$32
Kyowa Kirin, Inc.2$31
Springworks Therapeutics, Inc.1$30
Acorda Therapeutics, Inc2$29
Takeda Pharmaceuticals U.S.A., Inc.1$28
Merck2$28
Vertical Pharmaceuticals, LLC2$27
Sanofi2$26
Hoffmann-la Roche Limited1$25
Collegium Pharmaceutical, Inc.4$25
Neurelis, Inc.1$22
Greenwich Biosciences, Inc.1$19
Neurocrine Biosciences, Inc.1$19
Metacel Pharmaceuticals LLC1$16

How this compares

$1,238,048 in reported general payments places this provider in the 95th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$448,578
Medicare patients
379
Services billed
46,713

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Abington

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →